NGX delists GSK shares from official list

2024-02-12 18:27:01

Tribune Online

THE Nigerian Exchange Limited (NGX) has delisted the shares of GlaxoSmithKline Consumer Nigeria (GSK) Plc from its Daily Official List of NGX.

According to the Exchange's Weekly Report, the delisting follows the NGX's approval of the Company's application to delist its entire issued share capital.

"We refer to our market bulletin of 23 January 2024 with reference Number: NGXREG/LRD/MB4/24/01/23 wherein the market was notified of the full suspension placed on trading in the securities of GlaxoSmithKline Consumer Nigeria Plc (GSK or the Company) in preparation for the delisting of the company, the statement said.

Following the approval of the company's application to delist its entire issued share capital from the Nigerian Exchange Limited (NGX), please be informed that the entire issued share capital of GSK was on Monday, 5 February 2024, delisted from the Daily Official List of NGX."

The NGX had suspended trading on the shares of Glaxo SmithKline Consumer Nigeria (GSK) Plc for eventual delisting from the exchange.

The suspension followed the approval of the Scheme of Arrangement Glaxo SmithKline Consumer Nigeria Plc between the company and holders of its fully paid ordinary shares by the Securities and Exchange Commission and the sanctioning of the Scheme of Arrangement by the Federal High Court.

Registrars to update the register of members for payment

According to the report, the suspension was to enable the registrars to update the register of members for payment of the scheme consideration and eventual delisting of the company from the NGX.

2024-02-12 News